FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

FOUNTAINHEAD CAPITAL MANAGEMENT LTD 		2. Issuer Name and Ticker or Trading Symbol

VYCOR MEDICAL INC [ VYCO ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      __ X __ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

PORTMAN HOUSE HUE STREET, ST HELIER 		3. Date of Earliest Transaction (MM/DD/YYYY)

3/31/2017
(Street)

JERSEY CHANNEL ISLANDS, X0 JE45RP
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Preferred Series D par value $0.0001                  188.363   D    
Common Stock par value $0.0001   3/31/2017     A    142857   (1) A $0.21   7047899   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant   $1.88                    2/10/2010   8/4/2017   Common Stock   343.411     343.411   D    
Warrant   $2.62                    9/29/2010   8/4/2017   Common Stock   337.517     337.517   D    
Warrant   $3.08                    8/4/2014   8/4/2017   Common Stock   572.613     572.613   D    
Warrant   $2.05                    4/25/2014   4/24/2017   Common Stock   878     878   D    
Warrant   $3.08                    4/25/2014   4/24/2017   Common Stock   878     878   D    
Warrant   $0.27                    1/11/2017   1/10/2020   Common Stock   1924697     1924697   D    
Warrant   $0.27                    2/23/2017   2/22/2010   Common Stock   351204     351204   D    

Explanation of Responses:
(1)  Payment of consulting fee in stock.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
FOUNTAINHEAD CAPITAL MANAGEMENT LTD
PORTMAN HOUSE HUE STREET
ST HELIER
JERSEY CHANNEL ISLANDS, X0 JE45RP
X


Signatures
/s/ Mark Andrews For and on behalf of Berwin Limited Director 4/6/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Vycor Medical (QB) (USOTC:VYCO)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Vycor Medical (QB) Charts.
Vycor Medical (QB) (USOTC:VYCO)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Vycor Medical (QB) Charts.